Search Login Register

Plasminogen Activator Inhibitor 1 Summary

Description: A member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activators.

Also Known As: Serpin E1; Type 1 Plasminogen Activator Inhibitor; E1, Serpin; PAI-1

Networked: 3293 relevant articles (90 outcomes, 501 trials/studies) for this Bio-Agent

Key Diseases for which Plasminogen Activator Inhibitor 1 is Relevant

  1. Neoplasms (Cancer) : 9 outcomes 51 studies in 468 results
  2. Fibrosis (Cirrhosis) : 7 outcomes 13 studies in 185 results
  3. Inflammation : 6 outcomes 17 studies in 168 results
  4. Weight Loss (Weight Reduction) : 6 outcomes 5 studies in 35 results
  5. Myocardial Infarction : 5 outcomes 26 studies in 130 results
Show All >>

Drugs Related to Plasminogen Activator Inhibitor 1

  1. Plasminogen Activators (Plasminogen Activator)
  2. Antigens
  3. Insulin (Novolin)
  4. Tissue Plasminogen Activator (Alteplase)
  5. Fibrin
  6. Urokinase-Type Plasminogen Activator (Urokinase)
  7. Messenger RNA (mRNA)
  8. Fibrinogen (Factor I)
  9. Plasminogen Activator Inhibitor 2
  10. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
Show All >>

Therapies Related to Plasminogen Activator Inhibitor 1

  1. Thrombolytic Therapy
  2. Liver Transplantation
  3. Angioplasty (Angioplasty, Transluminal)
  4. Transplants (Transplant)
  5. Adjuvant Chemotherapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.